RSD-1122

N/A

Report date: 2023/02/18 16:53:05
NME

Base Information

Drug NameRSD-1122
Drug Alias NameRSD1122
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel modulators
TargetsPotassium channel
Therapy Area/IndicationsAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCardiome Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardiome Pharma
Active IndicationsN/A
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A